CorMedix, Inc. (CRMD)
6.25
-0.05
(-0.79%)
USD |
NASDAQ |
Mar 20, 16:00
6.30
+0.05
(+0.80%)
After-Hours: 20:00
CorMedix Research and Development Expense (Quarterly) : 8.60M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 23.74M |
| Pfizer Inc. | 3.133B |
| ANI Pharmaceuticals, Inc. | 12.26M |
| Castle Biosciences, Inc. | 13.44M |
| Indivior Pharmaceuticals, Inc. | 17.00M |